To evaluate the clinical relevance of perturbed CLR expression profiles on circulating and tumor-infiltrating DC subsets of melanoma patients, we studied their association with the clinical outcome of patients by performing multiple regressions (Cox regression; Kaplan-Meier; Supplementary Tables 5 and 6 respectively). The gene discussed is DCLK3; the disease is neoplasm.